Wnt/β-catenin pathway inhibitors, bone metabolism and vascular health in kidney transplant patients.
Yue-Pei WangAboubacar SidibéCatherine FortierMarie-Pier DesjardinsRoth-Visal UngRichard KremerMohsen AgharaziiFabrice Mac-WayPublished in: Journal of nephrology (2023)
The circulating levels of Wnt/β-catenin pathway inhibitors and α-klotho significantly decrease after kidney transplantation, while sclerostin and FGF23 levels might be associated with improvement of vascular stiffness and blood pressure.
Keyphrases
- blood pressure
- end stage renal disease
- stem cells
- cell proliferation
- ejection fraction
- public health
- healthcare
- newly diagnosed
- chronic kidney disease
- prognostic factors
- mental health
- peritoneal dialysis
- bone mineral density
- type diabetes
- adipose tissue
- soft tissue
- patient reported outcomes
- climate change
- health information
- body composition
- weight loss
- blood glucose